Topics and Expertise: Insulin

Gov. Newsom says California will make its own low-cost insulin

Fri Jul 15, 2022

Diabetes Treatments of the Future: Insulin-Producing Cell Implants

Mon Dec 11, 2017

Novel diabetes treatment developed in Desai Lab to power SF-area startup

Thu Oct 19, 2017
device alongside a quarter to show size
Encellin

The cell encapsulation device (right) that is being developed by Encellin, a San Francisco–based biotechnology company.

A UC San Francisco-created, insulin-generating implant that utilizes nanotechnology is closer to becoming a real treatment for diabetes, after being acquired by a San Francisco-based startup.

Insulin-producing pancreatic cells created from human skin cells

Thu Jan 7, 2016
Scientists at the Gladstone Institutes, the Diabetes Center at UCSF, and the UCSF School of Pharmacy have converted human skin cells into fully functional pancreatic cells that produce insulin in response to changes in glucose levels.

Roy receives JDRF funding to develop implants to treat type 1 diabetes

Tue Sep 1, 2015
silicon nanopore membranes
© majedphoto.com

Silicon nanopore membranes developed in the Roy Lab will provide material to encapsulate pancreatic islets.

UCSF School of Pharmacy faculty member Shuvo Roy, PhD, has received a three-year $1 million grant to create surgically implantable capsules of donor pancreas cells to free type 1 diabetes patients from daily insulin injections and the disease’s potentially life-threatening complications.